News
05-10-2011, 02:11 PM
Development of a predictive test that included genomic signatures that indicated chemoresistance, chemosensitivity and endocrine sensitivity for women with newly diagnosed breast cancer identified patients with a high probability of survival following chemotherapy, according to a study in the May 11 issue of JAMA...
More... (http://www.medicalnewstoday.com/articles/224628.php)
More... (http://www.medicalnewstoday.com/articles/224628.php)